Tobacco CessationAddictionMental healthBehavioralDrugBehavioralPhase 4
What this study is
This study is investigating tobacco use and providing tobacco treatment among people experiencing homelessness in California, in San Francisco and Los Angeles.
What's being tested
- Nicotine Replacement Therapy (NRT)
Intervention · DRUG
NRT will be administered as patch (transdermal), gum, or lozenge
- Wellness Coaching
Intervention · BEHAVIORAL
Delivered via phone call
Study details
- Sponsor
- University of California, San Francisco
- Conditions
- Tobacco Cessation · Tobacco Abstinence · Tobacco Use · Tobacco Use Cessation · Tobacco Dependence
- Enrolling
- 150 people
- Starts
- 2025-11-14
- Est. completion
- 2027-06-30
- Design
- Open-label, randomized, parallel groups, Phase 4
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years and overSex ALLHealthy volunteers Not acceptedYou may qualify if
- Age 18 years or older
- Able to understand study procedures and to comply with them for the entire length of the study.
- Ability of individual to understand a written informed consent document, and the willingness to sign it.
- Staying at the recruitment site and meeting criteria for homelessness as defined by the Homeless Emergency and Rapid Transition to Housing Act.
- Current smoking (smoking at least 5 cigarettes per day (cpd), verified via expired carbon monoxide (CO) >= 8 ppm using Micro+pro Smokerlyzer).
- Having an intention to quit smoking within the next six months.
- English speaking.
You can't join if
- Contraindication to any study-related procedure or assessment.
- Reasons that preclude the use of nicotine replacement therapy (NRT) (e.g., pregnancy or myocardial infarction in the past two weeks).
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
1
Study locations (1)
1 openUniversity of California, San Francisco
San Francisco, California, United States
- Jessica Alway · Contact877-827-3222jessica.alway@ucsf.edu
- Maya Vijayaraghavan, MD · Contact628-206-6959maya.vijayaraghavan@ucsf.edu
Recruiting
Study team
Sponsor
University of California, San Francisco
Study ID 25632
Principal investigator
Maya Vijayaraghavan, MD
University of California, San Francisco
Have questions? The contacts above can answer them before you apply.
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.